QT Imaging Projects $39M Revenue for 2026, Secures CPT Code & Expands Globally

summarizeResumen

This filing, an investor presentation, provides significant updates following the company's Q4 and full-year 2025 financial results announced on February 18, 2026. The company reported record 2025 revenue of $18.9 million, surpassing its guidance. Crucially, QT Imaging Holdings projects approximately $39 million in revenue for 2026, a substantial increase that represents roughly 60% of its current market capitalization. This ambitious guidance is bolstered by the recent approval of a new Category III CPT code (X579T) by the AMA, effective January 1, 2027, which is a critical step for future reimbursement and commercialization of its breast imaging technology. Furthermore, the company has secured significant distribution agreements with committed minimum order quantities in the USA, Saudi Arabia, and the UAE, indicating strong international expansion. The strategic shift towards a hardware-plus-SaaS platform also positions the company for sustainable, data-centric growth. Investors should monitor the execution of these commercial agreements and the progress towards full CPT code implementation.

check_boxEventos clave

• Record Q4 and FY25 Revenue

  The company achieved record commercial revenue of $8.3 million in Q4 2025 (877% YOY growth) and $18.9 million for the full year 2025, exceeding its guidance of $18.0 million.

• Strong 2026 Revenue Guidance

  QT Imaging projects approximately $39 million in revenue for 2026, driven by scanner shipments and initial revenue from its SaaS Cloud Platform.

• New CPT Code Approval

  The AMA approved a new Category III CPT code (X579T) in February 2026, scheduled for release on July 1, 2026, with an effective date of January 1, 2027, recognizing the company's 3D breast imaging platform.

• International Market Expansion

  Secured distribution agreements with NXC Imaging (USA), Gulf Medical (KSA), and Al Naghi Medical (UAE), including committed minimum order quantities for scanner shipments through 2028.

auto_awesomeAnalisis

This filing, an investor presentation, provides significant updates following the company's Q4 and full-year 2025 financial results announced on February 18, 2026. The company reported record 2025 revenue of $18.9 million, surpassing its guidance. Crucially, QT Imaging Holdings projects approximately $39 million in revenue for 2026, a substantial increase that represents roughly 60% of its current market capitalization. This ambitious guidance is bolstered by the recent approval of a new Category III CPT code (X579T) by the AMA, effective January 1, 2027, which is a critical step for future reimbursement and commercialization of its breast imaging technology. Furthermore, the company has secured significant distribution agreements with committed minimum order quantities in the USA, Saudi Arabia, and the UAE, indicating strong international expansion. The strategic shift towards a hardware-plus-SaaS platform also positions the company for sustainable, data-centric growth. Investors should monitor the execution of these commercial agreements and the progress towards full CPT code implementation.